Patents
More topics under "A61P - Specific therapeutic activity of chemical compounds or medicinal preparations" (2,008,710)
A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
A61P 11 - Drugs for disorders of the respiratory system (87,767)
A61P 13 - Drugs for disorders of the urinary system (56,135)
A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
A61P 17 - Drugs for dermatological disorders (106,455)
A61P 19 - Drugs for skeletal disorders (81,981)
A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
A61P 23 - Anaesthetics (4,141)
A61P 25 - Drugs for disorders of the nervous system (183,225)
A61P 27 - Drugs for disorders of the senses (53,017)
A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
A61P 3 - Drugs for disorders of the metabolism (129,789)
A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
A61P 33 - Antiparasitic agents (21,787)
A61P 35 - Antineoplastic agents (221,099)
A61P 37 - Drugs for immunological or allergic disorders (117,141)
A61P 39 - General protective or antinoxious agents (19,019)
A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
A61P 5 - Drugs for disorders of the endocrine system (28,908)
A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181)
05/2001
05/03/2001WO2000066164A8 Contraceptive compositions containing antiprogestinic and progestinic
05/03/2001CA2389020A1 Sodium-hydrogen exchanger type 1 inhibitor crystals
04/2001
04/26/2001WO2001029026A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
04/26/2001WO2001028992A2 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
04/26/2001CA2386910A1 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
04/25/2001CN1292279A Medicine for curing emmeniopathy and its preparation method
04/19/2001WO2001027113A2 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES
04/19/2001WO2001027112A1 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors
04/19/2001CA2387353A1 Pharmaceutically active compounds
04/12/2001WO2001025242A1 Novel thiazolo(4,5-d)pyrimidine compounds
04/12/2001WO2001025200A1 Cyclic amine compounds as ccr5 antagonists
04/12/2001WO2000076958A3 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
04/12/2001CA2608807A1 Cyclic amine compounds as ccr5 antagonists
04/05/2001WO2001022972A2 Immunostimulatory nucleic acids
04/05/2001CA2388055A1 Immunostimulatory nucleic acids
04/03/2001US6211208 2-aminopyridines containing fused ring substituents
03/2001
03/29/2001WO2001021596A1 Quinazoline derivatives and their use as pharmaceuticals
03/29/2001WO2001021594A1 Quinazoline compounds and pharmaceutical compositions containing them
03/29/2001WO2000051576A3 Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain
03/29/2001CA2384291A1 Quinazoline derivatives and their use as pharmaceuticals
03/29/2001CA2384282A1 Quinazoline compounds and pharmaceutical compositions containing them
03/22/2001WO2001019825A1 Pteridinones as kinase inhibitors
03/22/2001CA2393896A1 Pteridinones as kinase inhibitors
03/15/2001WO2001017976A1 Bis-sulfonamides
03/15/2001WO2001017957A1 Prostaglandin e analogues
03/15/2001WO2001017539A1 Herbal compositions for itchy or infected skin
03/15/2001WO2001017504A1 Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system
03/15/2001CA2384148A1 Prostaglandin e analogues
03/08/2001WO2001015732A1 Remedies for immunological diseases
03/08/2001WO2001015701A1 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
03/08/2001WO2000041546A9 Novel exendin agonist formulations and methods of administration thereof
03/01/2001WO2001014380A1 Isomeric fused pyrrolocarbazoles and isoindolones
03/01/2001WO2001014376A1 Novel spiro compounds
03/01/2001WO2001014353A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
02/2001
02/27/2001US6194408 Parasiticides
02/22/2001WO2001012627A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
02/22/2001WO2001012611A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
02/22/2001WO2000071538A3 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
02/22/2001WO2000023065A8 Storable active substance concentrate with formoterol
02/22/2001CA2381975A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
02/22/2001CA2381551A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
02/21/2001CN1062151C Medicinal compsn. for treatment of heperosteogeny and its prepn.
02/20/2001US6191140 Potassium channel modulators; muscle relaxants; controlling cell membranes
02/01/2001WO2000056359A3 Vaccine against streptococcus pneumoniae
01/2001
01/25/2001WO2000056360A3 Vaccine against antigens from bacteriae
01/18/2001WO2001003712A1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement
01/11/2001WO2001002403A1 METHOD FOR PREPARING SUBSTITUTED [1,4]DIAZEPINO[6,7,1-hi]INDOL-4-ONES
01/11/2001WO2000062800A3 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
01/11/2001CA2376707A1 Process for the preparation of substituted ¬1,4|diazepino¬6,7,1-hi|indol-4-ones
01/04/2001WO2000056358A3 Vaccine against streptococcus pneumoniae capsular polysaccharides
12/2000
12/28/2000WO2000078759A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2,2,2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as nk-1 receptor antagonists
12/28/2000CA2375265A1 Polymorphs of crystalline azo-bicyclo 2,2,2,oct-3-yl amine dihydrochloride and their pharmaceutical compositions
12/21/2000WO2000076961A1 Inhibitors of aspartyl protease
12/21/2000WO2000076958A2 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
12/21/2000WO2000050047A3 Composition for the treatment of psoriasis
12/21/2000CA2689997A1 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
12/14/2000WO2000044763A3 Compositions for treating inflammatory response
12/07/2000WO2000073303A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2.2.2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists
12/07/2000WO2000073298A1 Mutual prodrugs of amlodipine and atorvastatin
12/07/2000WO2000072855A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
12/07/2000WO2000037141A9 Combination chemotherapy
12/07/2000CA2372236A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo¬2,2,2|oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists
11/2000
11/30/2000WO2000071557A1 13-methyl-erythromycin derivatives
11/30/2000WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
11/30/2000WO2000041546A3 Novel exendin agonist formulations and methods of administration thereof
11/29/2000CN1274602A Externally applied medicated wine for treating traumatic injury and rheumatism
11/21/2000US6150418 Propellant-free concentrate suitable for storage containing given concentration of formoterol, or salt or addition products thereof as active substance in a solvent or suspension agent; use in inhalation therapy
11/16/2000CA2369605A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
11/09/2000WO2000066603A1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
11/09/2000WO2000066602A1 3-deoxy-desmycosin derivatives and process for their preparation
11/09/2000WO2000066556A1 Indoline derivatives as progesterone antagonists
11/09/2000WO2000066164A1 Contraceptive compositions containing antiprogestinic and progestinic
11/09/2000WO2000042031A3 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
11/09/2000CA2372977A1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
11/09/2000CA2372773A1 Contraceptive compositions containing antiprogestinic and progestinic
11/09/2000CA2371638A1 Indoline derivatives as progesterone antagonists
11/09/2000CA2368249A1 3-deoxy-desmycosin derivatives and process for their preparation
11/02/2000WO2000064450A1 Pharmaceutical composition
10/2000
10/26/2000WO2000062800A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/26/2000WO2000037064A3 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
10/26/2000WO2000025746A3 A process for the preparation of suspensions of drug particles for inhalation delivery
10/19/2000WO2000061590A1 Process for preparing amine platinum complexes
10/18/2000CN1270592A Spiroazabicyclic heterocyclic compounds
10/12/2000CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/05/2000WO2000058292A1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
09/2000
09/28/2000WO2000056360A2 Vaccine against antigens from bacteriae
09/28/2000WO2000056359A2 Vaccine against streptococcus pneumoniae
09/28/2000WO2000056358A2 Vaccine against streptococcus pneumoniae capsular polysaccharides
09/28/2000WO2000056348A1 Inflammatory mediation obtained from atractylodes lancea
09/28/2000CA2367699A1 Inflammatory mediation obtained from atractylodes lancea
09/28/2000CA2366152A1 Streptococcus pneumoniae vaccine
09/28/2000CA2365296A1 Vaccine
09/20/2000CN1267215A Pharmacetical compositions contg. effervescent acid-base couple
09/12/2000CA2212794C Oil in water emulsions containing propofol and edetate
09/08/2000WO2000051602A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity
09/08/2000WO2000051576A2 Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain
09/08/2000CA2366318A1 Novel pharmaceutical, dietary and cosmetic compositions comprising zinger officinale roscoe, eicosapentaenoic acid and/or docosahexaenoic acid
09/08/2000CA2362554A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity
09/06/2000EP1032408A1 Galenic preparation for prevention and treatment of hepatocarcinoma
09/06/2000CN1265597A Composition comprising propolis and at least an essential oil
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32